Jim Simons In Med Pharmaceuticals Inc. Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 50,296 shares of INM stock, worth $230,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,296Holding current value
$230,355% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding INM
# of Institutions
16Shares Held
1.14MCall Options Held
0Put Options Held
0-
Advisor Shares Investments LLC Bethesda, MD733KShares$3.36 Million0.03% of portfolio
-
Ubs Group Ag212KShares$971,1380.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il56.7KShares$259,5300.0% of portfolio
-
Hrt Financial LP New York, NY38.4KShares$175,7300.0% of portfolio
-
Virtu Financial LLC New York, NY28.4KShares$130,1400.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $4.16M
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...